Directory
>
Ken Kobayashi Md
Ken Kobayashi Md
Chief Medical Officer | Dr.Evidence
San Diego, California, United States
Ken Kobayashi Md
Summary
Ken Kobayashi is a seasoned oncologist and clinical pharmacologist with over two decades of experience in drug development, notably in the biotechnology and pharmaceutical sectors. His career is distinguished by the successful introduction of 28 investigational agents into clinical settings across Japan and the US, including five first-in-human trials. Ken's unique perspective stems from his roles on both the industry and regulatory sides, having contributed to numerous NDA, IND, and Breakthrough filings globally. He is recognized for his integrity and hands-on leadership style, often leading by example in cross-functional teams. Ken excels in strategic thinking and has a proven track record of guiding organizations through complex challenges, particularly in the realm of oncology. He is also a polished communicator, adept at engaging diverse audiences, from corporate executives to the lay public. His commitment to innovation and sustainable solutions has set new benchmarks in global drug development. Ken's passion for bridging science and business continues to drive his professional journey.
Ken Kobayashi Md
Work Experience
Chief Medical Officer at
Pyxis Oncology
November 2023 - Present
Advisory Board Member at
Dr.Evidence
May 2023 - Present
President at
Small Woods Biopharma Consulting, LLC
September 2022 - Present
Senior Vice President at
Kinnate Biopharma Inc.
June 2021 - September 2022
Vice President at
Pfizer, Inc.
March 2019 - June 2021
Executive Director at
Daiichi Sankyo US
October 2016 - March 2019
Executive Director Physician-Oncology at
AstraZeneca
February 2015 - October 2016
Oncology Regional Therapeutic Area Expert, Americas at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2014 - February 2015
Therapeutic Area Lead, Oncology, Janssen Pharma KK at
The Janssen Pharmaceutical Companies of Johnson & Johnson
August 2013 - January 2014
Therapeutic Area Head, Oncology, Janssen Pharma KK at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2011 - August 2013
Executive Director at
Novartis
July 2004 - January 2011
Senior Clinical Investigator at
National Cancer Institute (NCI)
June 2002 - July 2004
Senior Medical Reviewer at
FDA
July 1996 - June 2002
Mike Mansfield Fellow at
The Maureen and Mike Mansfield Foundation
September 1999 - September 2001
Fellow, Medical Oncology and Clinical Pharmacology at
The University of Chicago
July 1991 - June 1996
Resident, Internal Medicine at
Northwestern Memorial Hospital
July 1988 - June 1991
Resident, General Surgery at
The Medical College of Wisconsin Inc
July 1986 - June 1988
Ken Kobayashi Md
Education
Northwestern University - The Feinberg School of Medicine, Md
January 1982 - January 1986
Washington University in St. Louis, Ab
January 1978 - January 1982
Frequently Asked Questions about Ken Kobayashi Md
What is Ken Kobayashi Md email address?
Ken Kobayashi Md's primary email address is **********@pyxisoncology.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ken Kobayashi Md work for?
Ken Kobayashi Md is a Chief Medical Officer at Dr.Evidence, a company specializing in Prepackaged software.
Where Ken Kobayashi Md graduated from?
Ken Kobayashi Md holds a degree in Medicine from Northwestern University - The Feinberg School of Medicine.
How can I directly contact Ken Kobayashi Md?
To contact Ken Kobayashi Md directly, you can use the email address **********@pyxisoncology.com. Complete contact information is available upon registration with Muraena.
Who is Ken Kobayashi Md?
Ken Kobayashi is a seasoned oncologist and clinical pharmacologist with over two decades of experience in drug development, notably in the biotechnology and pharmaceutical sectors. His career is distinguished by the successful introduction of 28 investigational agents into clinical settings across Japan and the US, including five first-in-human trials. Ken's unique perspective stems from his roles on both the industry and regulatory sides, having contributed to numerous NDA, IND, and Breakthrough filings globally. He is recognized for his integrity and hands-on leadership style, often leading by example in cross-functional teams. Ken excels in strategic thinking and has a proven track record of guiding organizations through complex challenges, particularly in the realm of oncology. He is also a polished communicator, adept at engaging diverse audiences, from corporate executives to the lay public. His commitment to innovation and sustainable solutions has set new benchmarks in global drug development. Ken's passion for bridging science and business continues to drive his professional journey.
Ken`s contact details
**********@pyxisoncology.com
*************@pfizer.com
**********@attglobal.net
Colleagues
VP of Software Engineering
Chief Technology Officer
Board member
Chief Executive Officer
SVP, Sales and Business Development
Chief Growth Officer
Senior Vice President, Marketing
CMO, Co-Founder
VP, Business Development
Vice President of Finance